PF 00217830
a D2 receptor partial agonist for treating schizophrenia and bipolar disorder; structure in first source
Also Known As:
3,4-dihydro-7-(4-(1-naphthalenyl)-1-piperazinyl)butoxy-1,8-naphthyridin-2(1H)-one; PF-00217830; PF-217830; PF00217830
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Akunne, Hyacinth C:
1 article
(05/2011)
|
2. | Choi, Chung:
1 article
(05/2011)
|
3. | Favor, David A:
1 article
(05/2011)
|
4. | Fay, Lorraine K:
1 article
(05/2011)
|
5. | Fitzgerald, Lawrence:
1 article
(05/2011)
|
6. | Johnson, Douglas S:
1 article
(05/2011)
|
7. | Nicholls, Kim:
1 article
(05/2011)
|
8. | Repine, Joseph T:
1 article
(05/2011)
|
9. | Serpa, Kevin A:
1 article
(05/2011)
|
10. | Snyder, Bradley J:
1 article
(05/2011)
|
Related Diseases
Related Drugs and Biologics